These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30806731)

  • 1. Power-Doppler perfusion phenotype in RA patients is dependent on anti-citrullinated peptide antibody status, not on rheumatoid factor.
    Gadeholt O; Feuchtenberger M; Wech T; Schwaneck EC
    Rheumatol Int; 2019 Jun; 39(6):1019-1025. PubMed ID: 30806731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study.
    Gadeholt O; Wech T; Schuh S; Scharbatke E; Ostermeier E; Tony HP; Schmalzing M
    Rheumatol Int; 2016 Dec; 36(12):1671-1675. PubMed ID: 27507259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.
    Gadeholt O; Hausotter K; Eberle H; Klink T; Pfeil A
    Clin Rheumatol; 2019 Sep; 38(9):2403-2410. PubMed ID: 31123977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting joint destruction in rheumatoid arthritis with power Doppler, anti-citrullinated peptide antibody, and joint swelling.
    Kirino Y; Hama M; Takase-Minegishi K; Kunishita Y; Kishimoto D; Yoshimi R; Asami Y; Ihata A; Oba MS; Tsunoda S; Ohno S; Ueda A; Takeno M; Ishigatsubo Y
    Mod Rheumatol; 2015; 25(6):842-8. PubMed ID: 25736364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
    Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
    Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
    Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
    Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
    Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
    Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH
    Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
    Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
    Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study.
    van Beers-Tas MH; Blanken AB; Nielen MMJ; Turkstra F; van der Laken CJ; Meursinge Reynders M; van Schaardenburg D
    Arthritis Res Ther; 2018 Dec; 20(1):279. PubMed ID: 30567606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking.
    Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Nyberg F; Tornling G; Klareskog L; Holmqvist M; Askling J
    Arthritis Rheumatol; 2021 Jan; 73(1):61-68. PubMed ID: 32799411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
    Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
    Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
    Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
    Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
    Frisell T; Holmqvist M; Källberg H; Klareskog L; Alfredsson L; Askling J
    Arthritis Rheum; 2013 Nov; 65(11):2773-82. PubMed ID: 23897126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    Murphy D; Mattey D; Hutchinson D
    PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.